These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

224 related items for PubMed ID: 9128967

  • 1. Proliferation and hypoxia in human squamous cell carcinoma of the cervix: first report of combined immunohistochemical assays.
    Kennedy AS, Raleigh JA, Perez GM, Calkins DP, Thrall DE, Novotny DB, Varia MA.
    Int J Radiat Oncol Biol Phys; 1997 Mar 01; 37(4):897-905. PubMed ID: 9128967
    [Abstract] [Full Text] [Related]

  • 2. Semiquantitative immunohistochemical analysis for hypoxia in human tumors.
    Raleigh JA, Chou SC, Bono EL, Thrall DE, Varia MA.
    Int J Radiat Oncol Biol Phys; 2001 Feb 01; 49(2):569-74. PubMed ID: 11173156
    [Abstract] [Full Text] [Related]

  • 3. Invasive oxygen measurements and pimonidazole labeling in human cervix carcinoma.
    Nordsmark M, Loncaster J, Chou SC, Havsteen H, Lindegaard JC, Davidson SE, Varia M, West C, Hunter R, Overgaard J, Raleigh JA.
    Int J Radiat Oncol Biol Phys; 2001 Feb 01; 49(2):581-6. PubMed ID: 11173158
    [Abstract] [Full Text] [Related]

  • 4. Pimonidazole: a novel hypoxia marker for complementary study of tumor hypoxia and cell proliferation in cervical carcinoma.
    Varia MA, Calkins-Adams DP, Rinker LH, Kennedy AS, Novotny DB, Fowler WC, Raleigh JA.
    Gynecol Oncol; 1998 Nov 01; 71(2):270-7. PubMed ID: 9826471
    [Abstract] [Full Text] [Related]

  • 5. GLUT-1 and CAIX as intrinsic markers of hypoxia in carcinoma of the cervix: relationship to pimonidazole binding.
    Airley RE, Loncaster J, Raleigh JA, Harris AL, Davidson SE, Hunter RD, West CM, Stratford IJ.
    Int J Cancer; 2003 Mar 10; 104(1):85-91. PubMed ID: 12532423
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. A clinical study of hypoxia and metallothionein protein expression in squamous cell carcinomas.
    Raleigh JA, Chou SC, Calkins-Adams DP, Ballenger CA, Novotny DB, Varia MA.
    Clin Cancer Res; 2000 Mar 10; 6(3):855-62. PubMed ID: 10741707
    [Abstract] [Full Text] [Related]

  • 8. Comparison between pimonidazole binding, oxygen electrode measurements, and expression of endogenous hypoxia markers in cancer of the uterine cervix.
    Jankovic B, Aquino-Parsons C, Raleigh JA, Stanbridge EJ, Durand RE, Banath JP, MacPhail SH, Olive PL.
    Cytometry B Clin Cytom; 2006 Mar 10; 70(2):45-55. PubMed ID: 16456867
    [Abstract] [Full Text] [Related]

  • 9. Measurements of hypoxia using pimonidazole and polarographic oxygen-sensitive electrodes in human cervix carcinomas.
    Nordsmark M, Loncaster J, Aquino-Parsons C, Chou SC, Ladekarl M, Havsteen H, Lindegaard JC, Davidson SE, Varia M, West C, Hunter R, Overgaard J, Raleigh JA.
    Radiother Oncol; 2003 Apr 10; 67(1):35-44. PubMed ID: 12758238
    [Abstract] [Full Text] [Related]

  • 10. The fate of hypoxic (pimonidazole-labelled) cells in human cervix tumours undergoing chemo-radiotherapy.
    Durand RE, Aquino-Parsons C.
    Radiother Oncol; 2006 Aug 10; 80(2):138-42. PubMed ID: 16916562
    [Abstract] [Full Text] [Related]

  • 11. Comparison between the comet assay and pimonidazole binding for measuring tumour hypoxia.
    Olive PL, Durand RE, Raleigh JA, Luo C, Aquino-Parsons C.
    Br J Cancer; 2000 Dec 10; 83(11):1525-31. PubMed ID: 11076663
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Hypoxia in larynx carcinomas assessed by pimonidazole binding and the value of CA-IX and vascularity as surrogate markers of hypoxia.
    Hoogsteen IJ, Lok J, Marres HA, Takes RP, Rijken PF, van der Kogel AJ, Kaanders JH.
    Eur J Cancer; 2009 Nov 10; 45(16):2906-14. PubMed ID: 19699082
    [Abstract] [Full Text] [Related]

  • 16. HIF-1A, pimonidazole, and iododeoxyuridine to estimate hypoxia and perfusion in human head-and-neck tumors.
    Janssen HL, Haustermans KM, Sprong D, Blommestijn G, Hofland I, Hoebers FJ, Blijweert E, Raleigh JA, Semenza GL, Varia MA, Balm AJ, van Velthuysen ML, Delaere P, Sciot R, Begg AC.
    Int J Radiat Oncol Biol Phys; 2002 Dec 01; 54(5):1537-49. PubMed ID: 12459383
    [Abstract] [Full Text] [Related]

  • 17. Hypoxia and vascular endothelial growth factor expression in human squamous cell carcinomas using pimonidazole as a hypoxia marker.
    Raleigh JA, Calkins-Adams DP, Rinker LH, Ballenger CA, Weissler MC, Fowler WC, Novotny DB, Varia MA.
    Cancer Res; 1998 Sep 01; 58(17):3765-8. PubMed ID: 9731480
    [Abstract] [Full Text] [Related]

  • 18. An immunohistochemical assessment of hypoxia in prostate carcinoma using pimonidazole: implications for radioresistance.
    Carnell DM, Smith RE, Daley FM, Saunders MI, Bentzen SM, Hoskin PJ.
    Int J Radiat Oncol Biol Phys; 2006 May 01; 65(1):91-9. PubMed ID: 16563659
    [Abstract] [Full Text] [Related]

  • 19. Changes in tumor hypoxia measured with a double hypoxic marker technique.
    Ljungkvist AS, Bussink J, Rijken PF, Raleigh JA, Denekamp J, Van Der Kogel AJ.
    Int J Radiat Oncol Biol Phys; 2000 Dec 01; 48(5):1529-38. PubMed ID: 11121659
    [Abstract] [Full Text] [Related]

  • 20. Immunohistochemical expression of MIB-1 and PCNA in precancerous and cancerous lesions of uterine cervix.
    Goel MM, Mehrotra A.
    Indian J Cancer; 2013 Dec 01; 50(3):200-5. PubMed ID: 24061459
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.